A Phase I Clinical Study to Evaluate Effect of High-Fat Diet on Pharmacokinetics of a Single Oral Dose of SHR7280 Tablets and to Assess the Effect of SHR7280 on QT Interval in Healthy Subjects
Latest Information Update: 20 May 2025
At a glance
- Drugs SHR 7280 (Primary)
- Indications Endometriosis; Uterine leiomyoma
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
Most Recent Events
- 20 May 2025 New trial record